Phase IIa Trial of Anti-CD19 CAR T-Cells in Systemic Sclerosis Resistant to Immunosuppressive Therapy
Clinical trial NCT07493395 · RECRUITING
Trial details
- NCT number
- NCT07493395
- Sponsor
- University Hospital, Montpellier
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-11
- Primary completion
- 2028-06-11
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.